PF4’s primary physiological role is the neutralization of heparin-like molecules on the endothelial surface of blood vessels, thereby inhibiting local antithrombin activity and promoting coagulation. This function is essential for wound repair and inflammation . PF4 is also a strong chemoattractant for neutrophils, fibroblasts, and monocytes, and interacts with a splice variant of the chemokine receptor CXCR3, known as CXCR3-B .
PF4 is clinically significant in several contexts:
PF4 has been found to kill malaria parasites within erythrocytes by selectively lysing the parasite’s digestive vacuole . It also has antiproliferative and antiangiogenic properties, interfering with FGF2 and VEGF heparin binding and thus inhibiting their signaling . However, it can also be proinflammatory and proatherogenic through multiple effects on monocytes, macrophages, and endothelial cells .